We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

113 hedge funds and large institutions have $515M invested in Albany Molecular Research Inc in 2014 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more call options, than puts

Call options by funds: $6.15M | Put options by funds: $2.52M

95% more capital invested

Capital invested by funds: $264M → $515M (+$251M)

3% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 36

4% less funds holding

Funds holding: 118 → 113 (-5)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

Holders
113
Holders Change
-5
Holders Change %
-4.24%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
23
Increased
37
Reduced
36
Closed
28
Calls
$6.15M
Puts
$2.52M
Net Calls
+$3.63M
Net Calls Change
+$3.46M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$13.3M
2
HM
HealthCor Management
New York
+$12.4M
3
DCM
Decade Capital Management
New York
+$8.95M
4
BIM
Bogle Investment Management
Massachusetts
+$7.21M
5
HVC
Healthcare Value Capital
New Jersey
+$6.17M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$15.9M
2
BIT
BlackRock Institutional Trust
California
-$8.91M
3
CS
Credit Suisse
Switzerland
-$2.47M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.42M
5
SFM
Systematic Financial Management
New Jersey
-$1.73M
Name Holding Trade Value Shares
Change 		Change in
Stake
U
101
UBS
Switzerland
$56K +$11.2K +814 +37%
First Manhattan
102
First Manhattan
New York
$55K – – –
TRCT
103
Tower Research Capital (TRC)
New York
$38K -$18.5K -1,342 -40%
BPBT
104
Boston Private Bank & Trust
Massachusetts
$34K – – –
BlackRock
105
BlackRock
New York
$11K – – –
FWM
106
Focused Wealth Management
New York
$6K -$2.48K -180 -35%
LTFS
107
Ladenburg Thalmann Financial Services
Florida
$6K +$4.68K +340 New
GC
108
Globeflex Capital
California
$4K – – –
Ameriprise
109
Ameriprise
Minnesota
$4K +$69 +5 +2%
Wells Fargo
110
Wells Fargo
California
$4K +$2.53K +184 +329%
TPSF
111
Texas Permanent School Fund
Texas
$4K +$2.75K +200 New
AllianceBernstein
112
AllianceBernstein
Tennessee
$2K -$54.1K -3,929 -98%
Manulife (Manufacturers Life Insurance)
113
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$329 -$14.4K -1,048 -6%
SFM
114
Systematic Financial Management
New Jersey
– -$1.73M -171,916 Closed
AG
115
Algert Global
California
– -$1.21M -120,190 Closed
LSV Asset Management
116
LSV Asset Management
Illinois
– -$1.17M -116,427 Closed
BMCMI
117
Bryn Mawr Capital Management Inc
Pennsylvania
– -$606K -60,147 Closed
CAM
118
ClariVest Asset Management
California
– -$580K -57,563 Closed
Arrowstreet Capital
119
Arrowstreet Capital
Massachusetts
– -$549K -54,513 Closed
SIM
120
Spark Investment Management
New York
– -$407K -40,500 Closed
PP
121
PDT Partners
New York
– -$371K -36,793 Closed
AL
122
Airain Ltd
Guernsey
– -$355K -35,185 Closed
CIC
123
Cornercap Investment Counsel
Georgia
– -$348K -34,485 Closed
EMG
124
Ellington Management Group
Connecticut
– -$347K -34,400 Closed
NI
125
Numeric Investors
Massachusetts
– -$337K -33,400 Closed
2 3 4
5
6

AMRI Hedge Fund Activity: Q1 2014 in Review

113 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q1 2014, worth a combined $515M — up 95% from $264M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of AMRI and 23 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 37 added.

The largest buyer was Millennium Management, adding an estimated $13.3M. The largest seller was Wellington Management Group, cutting an estimated $15.9M.

  • 113 institutional investors held Albany Molecular Research Inc (AMRI) as of Q1 2014, down from 118 in Q4 2013.
  • Funds reported $515M of Albany Molecular Research Inc stock for Q1 2014, up 95% quarter-over-quarter.
  • 23 funds opened new Albany Molecular Research Inc positions in Q1 2014 and 28 closed out, a net change of -5 holders.
  • The largest Albany Molecular Research Inc buyer in Q1 2014 was Millennium Management, an estimated $13.3M added.
  • The largest Albany Molecular Research Inc seller in Q1 2014 was Wellington Management Group, an estimated $15.9M sold.

Based on aggregated 13F filings for Q1 2014.